{"symbol": "JNJ", "publishedDate": "2022-01-18 15:23:05", "publisher": "Zacks Investment Research", "title": "Why You Should Invest in Dividend Growth ETFs Now", "image": "https://images.financialmodelingprep.com/news/why-you-should-invest-in-dividend-growth-etfs-now-20220118.jpg", "site": "zacks.com", "text": "We highlight 3 ultra-cheap ETFs that focus on high quality dividend payers", "url": "https://www.zacks.com/stock/news/1853579/why-you-should-invest-in-dividend-growth-etfs-now", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-18T15:23:05-05:00", "date_et": "2022-01-18"}
{"symbol": "JNJ", "publishedDate": "2022-01-18 16:33:53", "publisher": "GuruFocus", "title": "Pharma Giants Go After $10 Billion Market With RSV Drugs", "image": "https://images.financialmodelingprep.com/news/pharma-giants-go-after-10-billion-market-with-rsv-20220118.jpg", "site": "gurufocus.com", "text": "GlaxoSmithKline PLC ( GSK , Financial), Pfizer Inc. ( PFE , Financial) and Johnson & Johnson ( JNJ , Financial) should all know about mid-year if the shots they're developing for a common and potentially fatal virus is effective. No, the it isn't for Covid-19, but for respiratory syncytial virus, which causes an estimated 177,000 hospitalizations among older adults each year and 58,000 in children under five.", "url": "https://www.gurufocus.com/news/1619756/pharma-giants-go-after-10-billion-market-with-rsv-drugs", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-18T16:33:53-05:00", "date_et": "2022-01-18"}
{"symbol": "JNJ", "publishedDate": "2022-01-19 12:02:00", "publisher": "Market Watch", "title": "Earnings Outlook: What's next for a J&J that will soon be split into two different companies", "image": "https://images.financialmodelingprep.com/news/earnings-outlook-whats-next-for-a-jj-that-will-20220119.jpg", "site": "marketwatch.com", "text": "Johnson & Johnson JNJ, +0.74% has long been viewed as a bellwether stock for other health care companies, given its early slot in the earnings calendar and a business model that spans everything from hip implants to rheumatoid arthritis drugs and Band-Aids.", "url": "https://www.marketwatch.com/story/whats-next-for-a-j-j-that-will-soon-be-split-into-two-different-companies-11642611732", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-19T12:02:00-05:00", "date_et": "2022-01-19"}
{"symbol": "JNJ", "publishedDate": "2022-01-19 15:02:09", "publisher": "Stockmarket.com", "title": "Good Stocks To Invest In Right Now? 4 Defensive Stocks For Your List", "image": "https://images.financialmodelingprep.com/news/good-stocks-to-invest-in-right-now-4-defensive-20220119.jpg", "site": "stockmarket.com", "text": "Check out these defensive stocks amid choppy markets.", "url": "https://stockmarket.com/featured/good-stocks-to-invest-in-right-now-4-defensive-stocks-for-your-list-2022-01-19", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-19T15:02:09-05:00", "date_et": "2022-01-19"}
{"symbol": "JNJ", "publishedDate": "2022-01-21 07:30:08", "publisher": "Forbes", "title": "Will Johnson & Johnson Stock Rise After Q4 Results?", "image": "https://images.financialmodelingprep.com/news/will-johnson-johnson-stock-rise-after-q4-results-20220121.jpg", "site": "forbes.com", "text": "Johnson & Johnson stock is scheduled to report its Q4 2021 results on Tuesday, January 25. We expect J&J to report revenues and earnings above the consensus estimates.", "url": "https://www.forbes.com/sites/greatspeculations/2022/01/21/will-johnson--johnson-stock-rise-after-q4-results/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-21T07:30:08-05:00", "date_et": "2022-01-21"}
{"symbol": "JNJ", "publishedDate": "2022-01-21 10:30:00", "publisher": "The Motley Fool", "title": "2 Dividend Stocks to Buy and Hold Forever", "image": "https://images.financialmodelingprep.com/news/2-dividend-stocks-to-buy-and-hold-forever-20220121.jpg", "site": "fool.com", "text": "Some healthcare services will never become obsolete.", "url": "https://www.fool.com/investing/2022/01/21/2-dividend-stocks-to-buy-and-hold-forever/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-21T10:30:00-05:00", "date_et": "2022-01-21"}
{"symbol": "JNJ", "publishedDate": "2022-01-21 10:49:17", "publisher": "Zacks Investment Research", "title": "J&J (JNJ) to Set the Stage for Pharma Sector Q4 Earnings", "image": "https://images.financialmodelingprep.com/news/jj-jnj-to-set-the-stage-for-pharma-sector-20220121.jpg", "site": "zacks.com", "text": "J&J's (JNJ) Pharma segment is expected to have performed above the market. It remains to be seen if sales improved in the Medical Devices segment in the fourth quarter.", "url": "https://www.zacks.com/stock/news/1855319/j-j-jnj-to-set-the-stage-for-pharma-sector-q4-earnings", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-21T10:49:17-05:00", "date_et": "2022-01-21"}
{"symbol": "JNJ", "publishedDate": "2022-01-21 10:52:17", "publisher": "24/7 Wall Street", "title": "Earnings Previews: American Express, GE, Johnson & Johnson, 3M", "image": "https://images.financialmodelingprep.com/news/earnings-previews-american-express-ge-johnson-johnson-3m-20220121.jpg", "site": "247wallst.com", "text": "U.S. markets got off to a rocky start Friday morning. Netflix reported results Thursday afternoon that disappointed investors, primarily because of its uncertain guidance.", "url": "https://247wallst.com/investing/2022/01/21/earnings-previews-american-express-ge-johnson-johnson-3m/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-21T10:52:17-05:00", "date_et": "2022-01-21"}
{"symbol": "JNJ", "publishedDate": "2022-01-21 13:18:45", "publisher": "Stockmarket.com", "title": "Which Stocks To Buy Now? 4 Value Stocks To Watch", "image": "https://images.financialmodelingprep.com/news/which-stocks-to-buy-now-4-value-stocks-to-20220121.jpg", "site": "stockmarket.com", "text": "Should you be investing in these value stocks amid concerns of high inflation?", "url": "https://stockmarket.com/featured/which-stocks-to-buy-now-4-value-stocks-to-watch-2022-01-21", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-21T13:18:45-05:00", "date_et": "2022-01-21"}
{"symbol": "JNJ", "publishedDate": "2022-01-23 05:52:00", "publisher": "The Motley Fool", "title": "3 Dividend Stocks to Buy and Hold Forever", "image": "https://images.financialmodelingprep.com/news/3-dividend-stocks-to-buy-and-hold-forever-20220123.jpg", "site": "fool.com", "text": "All three have great dividends plus solid business models that are built for the long term.", "url": "https://www.fool.com/investing/2022/01/23/3-dividend-stocks-to-buy-and-hold-forever/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-23T05:52:00-05:00", "date_et": "2022-01-23"}
{"symbol": "JNJ", "publishedDate": "2022-01-24 07:30:11", "publisher": "Seeking Alpha", "title": "Johnson & Johnson: It's Not A Matter Of If But When To Add This Stock", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-its-not-a-matter-of-if-but-20220124.jpg", "site": "seekingalpha.com", "text": "JNJ is as close to recession-proof as you can get.", "url": "https://seekingalpha.com/article/4481148-johnson-and-johnson-add-jnj-stock", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-24T07:30:11-05:00", "date_et": "2022-01-24"}
{"symbol": "JNJ", "publishedDate": "2022-01-24 07:52:32", "publisher": "Seeking Alpha", "title": "Johnson & Johnson Is The Low Beta Stock Your Portfolio Needs", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-is-the-low-beta-stock-your-portfolio-20220124.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson is a low beta stock, with a very long track record of strong execution.", "url": "https://seekingalpha.com/article/4481150-johnson-and-johnson-jnj-low-beta-stock-buy", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-24T07:52:32-05:00", "date_et": "2022-01-24"}
{"symbol": "JNJ", "publishedDate": "2022-01-24 12:38:46", "publisher": "Seeking Alpha", "title": "Johnson & Johnson Stock: Spinning Off Its Litigations And Bankruptcy", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-stock-spinning-off-its-litigations-and-bankruptcy-20220124.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson (JNJ) will be spinning off its Consumer Health segment over the next 18 to 24 months, which faced over $2B in talc-related litigation claims. JNJ will also be seeking bankruptcy protection for the new company, similar to other companies facing multi-billion dollar litigations.", "url": "https://seekingalpha.com/article/4481229-johnson-and-johnson-stock-spinning-off-its-litigations-and-bankruptcy", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-24T12:38:46-05:00", "date_et": "2022-01-24"}
{"symbol": "JNJ", "publishedDate": "2022-01-24 12:44:05", "publisher": "Benzinga", "title": "Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows", "image": "https://images.financialmodelingprep.com/news/pfizer-astrazeneca-or-jj-covid19-shots-boost-sinovac-regime-20220124.jpg", "site": "benzinga.com", "text": "A third booster dose of a COVID-19 vaccine from either AstraZeneca Plc (NASDAQ: AZN), Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX), or Johnson & Johnson (NYSE: JNJ) increases antibody levels significantly in those who have previously received two doses of Sinovac Biotech Ltd (NASDAQ: SVA) CoronaVac. According to the study, CoronaVac received the strongest boost from a viral vector or RNA shot, including against the Delta and Omicron coronavirus variants.", "url": "https://www.benzinga.com/general/biotech/22/01/25189797/pfizer-astrazeneca-or-j-j-covid-19-shots-boost-sinovac-regime-brazilian-study-shows", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-24T12:44:05-05:00", "date_et": "2022-01-24"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 01:44:15", "publisher": "Seeking Alpha", "title": "Johnson & Johnson: The Right Prescription For A Turbulent Market", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-the-right-prescription-for-a-turbulent-market-20220125.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson: The Right Prescription For A Turbulent Market", "url": "https://seekingalpha.com/article/4481340-johnson-and-johnson-the-right-prescription-for-a-turbulent-market", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T01:44:15-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 06:25:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson Reports Q4 and Full-Year 2021 Results", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reports-q4-and-fullyear-2021-results-20220125.jpg", "site": "prnewswire.com", "text": "NEW BRUNSWICK, N.J., Jan. 25, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2021.", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-reports-q4-and-full-year-2021-results-301467057.html", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T06:25:00-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 06:29:00", "publisher": "Reuters", "title": "J&J expects up to $3.5 billion in COVID vaccine sales this year", "image": "https://images.financialmodelingprep.com/news/jj-expects-up-to-35-billion-in-covid-vaccine-20220125.jpg", "site": "reuters.com", "text": "Johnson & Johnson on Tuesday forecast $3 billion-$3.5 billion in revenue for its COVID-19 vaccine this year, more than the $2.39 billion it generated in 2021 even as the drugmaker faces manufacturing issues and uneven demand.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-expects-up-35-bln-covid-vaccine-sales-this-year-2022-01-25/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T06:29:00-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 06:45:44", "publisher": "Market Watch", "title": "J&J shares down 1.3% premarket after Q4 revenue lags consensus", "image": "https://images.financialmodelingprep.com/news/jj-shares-down-13-premarket-after-q4-revenue-lags-20220125.jpeg", "site": "marketwatch.com", "text": "Johnson & Johnson shares slid 1.3% premarket Tuesday, after the consumer goods, pharmaceutical and medical device maker posted weaker-than-expected revenue for the fourth quarter. The company posted net income of $4.736 billion, or $1.77 a share, for the quarter, up from $1.738 billion, or 65 cents a share, in the year-earlier period.", "url": "https://www.marketwatch.com/story/jj-shares-down-13-premarket-after-q4-revenue-lags-consensus-2022-01-25", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T06:45:44-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 07:14:10", "publisher": "Benzinga", "title": "Johnson & Johnson's FY21 COVID-19 Vaccine Sales Below Expectations", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-fy21-covid19-vaccine-sales-below-expectations-20220125.jpg", "site": "benzinga.com", "text": "Johnson & Johnson (NYSE: JNJ) has reported Q4 adjusted earnings of $2.13 per share, up 14.5% Y/Y over the $1.86 posted a year ago and marginally ahead of the consensus of $2.12. Net sales increased 10.4% Y/Y to $24.8 billion, missing the consensus of $25.29 billion.", "url": "https://www.benzinga.com/general/biotech/22/01/25203388/johnson-johnsons-fy21-covid-19-vaccine-sales-below-expectations", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T07:14:10-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 09:19:07", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Surpasses Q4 Earnings Estimates", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-surpasses-q4-earnings-estimates-20220125.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 0.47% and 1.77%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/1856663/johnson-johnson-jnj-surpasses-q4-earnings-estimates", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T09:19:07-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 09:26:33", "publisher": "InvestorPlace", "title": "Stocks to Watch Tuesday: What's Moving VZ, JNJ, GE, IBM and MMM Today", "image": "https://images.financialmodelingprep.com/news/stocks-to-watch-tuesday-whats-moving-vz-jnj-ge-20220125.jpg", "site": "investorplace.com", "text": "We're checking in on some of the top stocks to watch Tuesday as several major companies release Q4 earnings reports today! The post Stocks to Watch Tuesday: What's Moving VZ, JNJ, GE, IBM and MMM Today appeared first on InvestorPlace.", "url": "https://investorplace.com/2022/01/stocks-to-watch-tuesday-whats-moving-vz-jnj-ge-ibm-and-mmm-today/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T09:26:33-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 09:50:39", "publisher": "Invezz", "title": "J&J CFO on Q4 results: ‘we're very well positioned for 2022'", "image": "https://images.financialmodelingprep.com/news/jj-cfo-on-q4-results-were-very-well-positioned-20220125.jpg", "site": "invezz.com", "text": "Johnson & Johnson (NYSE: JNJ) on Tuesday reported lower-than-expected revenue for its fiscal fourth quarter. Shares still jumped 2.5% this morning on strong guidance for the future.", "url": "https://invezz.com/news/2022/01/25/jj-cfo-on-q4-results-were-very-well-positioned-for-2022/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T09:50:39-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 10:25:58", "publisher": "Schaeffers Research", "title": "Options Traders Eye Blue-Chip Stock After Earnings", "image": "https://images.financialmodelingprep.com/news/options-traders-eye-bluechip-stock-after-earnings-20220125.jpg", "site": "schaeffersresearch.com", "text": "Johnson & Johnson (NYSE:JNJ) is struggling for direction today, last seen up 0.3% to trade at $162.88, after the blue-chip concern posted slightly better-than-expected fourth-quarter earnings.", "url": "https://www.schaeffersresearch.com/content/news/2022/01/25/options-traders-eye-blue-chip-stock-after-earnings", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T10:25:58-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 12:23:10", "publisher": "Zacks Investment Research", "title": "Markets Await More Earnings Data", "image": "https://images.financialmodelingprep.com/news/markets-await-more-earnings-data-20220125.jpg", "site": "zacks.com", "text": "Markets Await More Earnings Data", "url": "https://www.zacks.com/stock/news/1856963/markets-await-more-earnings-data", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T12:23:10-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 12:23:16", "publisher": "Zacks Investment Research", "title": "J&J (JNJ) Q4 Earnings Beat Estimates by a Penny, Sales Miss", "image": "https://images.financialmodelingprep.com/news/jj-jnj-q4-earnings-beat-estimates-by-a-penny-20220125.jpg", "site": "zacks.com", "text": "J&J (JNJ) reports mixed fourth-quarter results. It beats estimates for earnings but misses the same for sales.", "url": "https://www.zacks.com/stock/news/1856945/j-j-jnj-q4-earnings-beat-estimates-by-a-penny-sales-miss", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T12:23:16-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 12:44:01", "publisher": "Seeking Alpha", "title": "Johnson & Johnson (JNJ) CEO Joaquin Duato on Q4 2021 Results - Earnings Call Transcript", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-ceo-joaquin-duato-on-q4-2021-20220125.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson (JNJ) CEO Joaquin Duato on Q4 2021 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4481509-johnson-and-johnson-jnj-ceo-joaquin-duato-on-q4-2021-results-earnings-call-transcript", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T12:44:01-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 13:35:41", "publisher": "PYMNTS", "title": "Johnson & Johnson Readies to Spin Off Business Units As COVID Effects Linger in 2022", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-readies-to-spin-off-business-units-as-20220125.jpg", "site": "pymnts.com", "text": "Moving to split its consumer health and medical device/pharma units into two separate public companies, the Johnson & Johnson (JNJ) version of “divide and conquer” revolves around increased ability to funnel research and investment into these new centers of excellence. Incoming CEO Joaquin Duato said separation of the consumer health, pharmaceutical and medical device businesses […]", "url": "https://www.pymnts.com/earnings/2022/johnson-johnson-readies-to-spin-off-business-units-as-covid-effects-linger/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T13:35:41-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-25 16:22:29", "publisher": "CNN", "title": "Johnson & Johnson expects its Covid vaccine sales to surge -- but still lag its rivals", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-expects-its-covid-vaccine-sales-to-surge-20220125.jpg", "site": "cnn.com", "text": "Johnson & Johnson, the world's largest health care products company, reported that sales of its Covid vaccine have accelerated, but they'll still lag far behind other vaccines for the foreseeable future.", "url": "https://www.cnn.com/2022/01/25/investing/johnson-and-johnson-vaccine-revenue/index.html", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-25T16:22:29-05:00", "date_et": "2022-01-25"}
{"symbol": "JNJ", "publishedDate": "2022-01-26 01:00:55", "publisher": "MarketBeat", "title": "Is It Time To Buy The Rebound In Johnson & Johnson?", "image": "https://images.financialmodelingprep.com/news/is-it-time-to-buy-the-rebound-in-johnson-20220126.jpg", "site": "marketbeat.com", "text": "Johnson & Johnson (NYSE: JNJ) shares are moving higher on a mixed report. The company missed on the top line but margins came in well above expectation and drove solid results on the bottom line.", "url": "https://www.marketbeat.com/originals/is-it-time-to-buy-the-rebound-in-johnson-and-johnson/?SNAPI?SNAPI", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-26T01:00:55-05:00", "date_et": "2022-01-26"}
{"symbol": "JNJ", "publishedDate": "2022-01-26 07:52:00", "publisher": "The Motley Fool", "title": "2 Top Dividend Kings to Buy for the Long Haul", "image": "https://images.financialmodelingprep.com/news/2-top-dividend-kings-to-buy-for-the-long-20220126.jpg", "site": "fool.com", "text": "The Dividend King club is an exclusive one. It takes good management to grow a dividend for 50 or more years, and these two healthcare stocks offer that.", "url": "https://www.fool.com/investing/2022/01/26/2-top-dividend-kings-to-buy-for-the-long-haul/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-26T07:52:00-05:00", "date_et": "2022-01-26"}
{"symbol": "JNJ", "publishedDate": "2022-01-26 18:01:00", "publisher": "Reuters", "title": "Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO", "image": "https://images.financialmodelingprep.com/news/drugmaker-galapagos-names-former-jj-exec-paul-stoffels-as-20220126.jpg", "site": "reuters.com", "text": "Belgian drugmaker Galapagos NV on Wednesday named former Johnson & Johnson senior executive Paul Stoffels as its chief executive officer, effective April 1.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/drugmaker-galapagos-names-former-jj-exec-paul-stoffels-ceo-2022-01-26/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-26T18:01:00-05:00", "date_et": "2022-01-26"}
{"symbol": "JNJ", "publishedDate": "2022-01-27 05:51:00", "publisher": "The Motley Fool", "title": "3 of the Safest Stocks to Buy if There's a Stock Market Crash", "image": "https://images.financialmodelingprep.com/news/3-of-the-safest-stocks-to-buy-if-theres-20220127.jpg", "site": "fool.com", "text": "This stock trio can help you successfully navigate heightened market volatility.", "url": "https://www.fool.com/investing/2022/01/27/3-of-the-safest-stocks-buy-if-stock-market-crash/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-27T05:51:00-05:00", "date_et": "2022-01-27"}
{"symbol": "JNJ", "publishedDate": "2022-01-27 16:57:16", "publisher": "GuruFocus", "title": "Johnson & Johnson Hunting for Biotech, Medical Device Acquisitions", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-hunting-for-biotech-medical-device-acquisitions-20220127.jpg", "site": "gurufocus.com", "text": "Johnson & Johnson ( JNJ , Financial) is on the lookout for medical device and biotech companies to add to the fold, but in the case of the latter, it might be beaten to the punch by a pair of Big Pharma rivals. One could be Novartis ( NVS , Financial), which recently sold its ownership in Roche ( RHHBY , Financial) and could add to its coffers if it divests the Sandoz generics unit, according to a BioPharma Dive article.", "url": "https://www.gurufocus.com/news/1627469/johnson--johnson-hunting-for-biotech-medical-device-acquisitions", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-27T16:57:16-05:00", "date_et": "2022-01-27"}
{"symbol": "JNJ", "publishedDate": "2022-01-27 17:28:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-citis-2022-virtual-healthcare-20220127.jpg", "site": "prnewswire.com", "text": "NEW BRUNSWICK, N.J., Jan. 27, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23 rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m.", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-citis-2022-virtual-healthcare-conference-301470256.html", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-27T17:28:00-05:00", "date_et": "2022-01-27"}
{"symbol": "JNJ", "publishedDate": "2022-01-28 08:36:00", "publisher": "The Motley Fool", "title": "Start Your Investing Resolutions Off Right With This Classic Stock Bundle", "image": "https://images.financialmodelingprep.com/news/start-your-investing-resolutions-off-right-with-this-classic-20220128.jpg", "site": "fool.com", "text": "These ten stocks are a great foundation for investors dealing with this market correction.", "url": "https://www.fool.com/investing/2022/01/28/start-your-investing-resolutions-off-right-with-th/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-28T08:36:00-05:00", "date_et": "2022-01-28"}
{"symbol": "JNJ", "publishedDate": "2022-01-28 15:25:53", "publisher": "Schaeffers Research", "title": "Dramatic Afternoon Trading Highlights Tumultuous Week on Wall Street", "image": "https://images.financialmodelingprep.com/news/dramatic-afternoon-trading-highlights-tumultuous-week-on-wall-street-20220128.jpg", "site": "schaeffersresearch.com", "text": "To say it was a volatile week on Wall Street would be an understatement.", "url": "https://www.schaeffersresearch.com/content/news/2022/01/28/dramatic-afternoon-trading-highlights-tumultuous-week-on-wall-street", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-28T15:25:53-05:00", "date_et": "2022-01-28"}
{"symbol": "JNJ", "publishedDate": "2022-01-29 07:00:00", "publisher": "Seeking Alpha", "title": "My Top Dividend Stocks For 2022", "image": "https://images.financialmodelingprep.com/news/my-top-dividend-stocks-for-2022-20220129.jpg", "site": "seekingalpha.com", "text": "My Top Dividend Stocks For 2022", "url": "https://seekingalpha.com/article/4482246-my-top-dividend-stocks-for-2022", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-29T07:00:00-05:00", "date_et": "2022-01-29"}
{"symbol": "JNJ", "publishedDate": "2022-01-29 08:58:52", "publisher": "Stockmarket.com", "title": "Best Dividend Stocks To Buy Now? 3 For Your List", "image": "https://images.financialmodelingprep.com/news/best-dividend-stocks-to-buy-now-3-for-your-20220129.jpg", "site": "stockmarket.com", "text": "Dividend stocks to watch as markets continue to be choppy.", "url": "https://stockmarket.com/featured/best-dividend-stocks-to-buy-now-3-for-your-list-2022-01-29", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-29T08:58:52-05:00", "date_et": "2022-01-29"}
{"symbol": "JNJ", "publishedDate": "2022-01-31 04:40:44", "publisher": "Seeking Alpha", "title": "10 High-Yield Sleep Well At Night Blue-Chips Perfect For This Correction", "image": "https://images.financialmodelingprep.com/news/10-highyield-sleep-well-at-night-bluechips-perfect-for-20220131.jpg", "site": "seekingalpha.com", "text": "Volatility is back on Wall Street, with tech suffering its worst month since 2008. No one knows how long or deep the 2022 correction will be, but prudent risk-management, not market timing is your best option for protecting your retirement nest egg.", "url": "https://seekingalpha.com/article/4482887-10-high-yield-sleep-well-at-night-blue-chips-perfect-for-this-correction", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-01-31T04:40:44-05:00", "date_et": "2022-01-31"}
{"symbol": "JNJ", "publishedDate": "2022-02-01 11:30:21", "publisher": "Zacks Investment Research", "title": "Pharma Stocks to Report Q4 Earnings on Feb 2: ABBV, NVS & NVO", "image": "https://images.financialmodelingprep.com/news/pharma-stocks-to-report-q4-earnings-on-feb-2-20220201.jpg", "site": "zacks.com", "text": "Let us take a look at three large pharma companies - ABBV, NVS and NVO - due to release their quarterly results on Feb 2.", "url": "https://www.zacks.com/stock/news/1860564/pharma-stocks-to-report-q4-earnings-on-feb-2-abbv-nvs-nvo", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-01T11:30:21-05:00", "date_et": "2022-02-01"}
{"symbol": "JNJ", "publishedDate": "2022-02-01 12:09:00", "publisher": "Reuters", "title": "Drug distributors, J&J to pay $590 million to settle U.S. tribes' opioid claims", "image": "https://images.financialmodelingprep.com/news/drug-distributors-jj-to-pay-590-million-to-settle-20220201.jpg", "site": "reuters.com", "text": "The three largest U.S. drug distributors and drugmaker Johnson & Johnson have agreed to pay $590 million to resolve claims by Native American tribes that the companies fueled an opioid epidemic in their communities, according to court filings.", "url": "https://www.reuters.com/article/us-usa-opioids-litigation/drug-distributors-jj-to-pay-590-million-to-settle-u-s-tribes-opioid-claims-idUSKBN2K63WG", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-01T12:09:00-05:00", "date_et": "2022-02-01"}
{"symbol": "JNJ", "publishedDate": "2022-02-02 13:01:28", "publisher": "GuruFocus", "title": "A Trio of High-Yield Stocks for Dividend Investors", "image": "https://images.financialmodelingprep.com/news/a-trio-of-highyield-stocks-for-dividend-investors-20220202.jpeg", "site": "gurufocus.com", "text": "Dividend investors could be interested in the following stocks, since they offer much higher dividend yields than the S&P 500 Index. The U.S. benchmark index yields 1.32% as of the close of trading on Tuesday.", "url": "https://www.gurufocus.com/news/1632632/a-trio-of-highyield-stocks-for-dividend-investors", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-02T13:01:28-05:00", "date_et": "2022-02-02"}
{"symbol": "JNJ", "publishedDate": "2022-02-02 13:39:56", "publisher": "Benzinga", "title": "Johnson & Johnson, Distributors Reach $590M Opioid Settlement For Tribe Claims: Report", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-distributors-reach-590m-opioid-settlement-for-tribe-20220202.jpg", "site": "benzinga.com", "text": "Johnson & Johnson JNJ and the three U.S. drug distributors agreed to pay about $590 million to resolve claims from over 400 Native American tribes to settle lawsuits over the opioid epidemic. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School.", "url": "https://www.benzinga.com/general/biotech/22/02/25373905/johnson-johnson-distributors-reach-590m-opioid-settlement-for-tribe-claims-report", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-02T13:39:56-05:00", "date_et": "2022-02-02"}
{"symbol": "JNJ", "publishedDate": "2022-02-03 07:05:00", "publisher": "The Motley Fool", "title": "Here's What to Like About Johnson & Johnson's Q4 Update", "image": "https://images.financialmodelingprep.com/news/heres-what-to-like-about-johnson-johnsons-q4-update-20220203.jpg", "site": "fool.com", "text": "The pharmaceutical segment continues to be J&J's biggest growth driver.", "url": "https://www.fool.com/investing/2022/02/03/heres-what-to-like-about-johnson-johnsons-q4-updat/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-03T07:05:00-05:00", "date_et": "2022-02-03"}
{"symbol": "JNJ", "publishedDate": "2022-02-03 13:39:45", "publisher": "Benzinga", "title": "Janssen Inks Over $1B Pact For Mersana's ADC Technology In Three targets", "image": "https://images.financialmodelingprep.com/news/janssen-inks-over-1b-pact-for-mersanas-adc-technology-20220203.jpg", "site": "benzinga.com", "text": "Mersana Therapeutics Inc MRSN has announced a research collaboration and license agreement with Janssen Biotech Inc, a unit of Johnson & Johnson JNJ, to discover antibody-drug conjugates (ADCs) for three targets. Get the Inside Access Traders Are Using to Profit More and Win Bigger.", "url": "https://www.benzinga.com/general/biotech/22/02/25400148/janssen-inks-over-1b-pact-for-mersanas-adc-technology-in-three-targets", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-03T13:39:45-05:00", "date_et": "2022-02-03"}
{"symbol": "JNJ", "publishedDate": "2022-02-04 14:23:00", "publisher": "Reuters", "title": "Special Report-Inside J&J's secret plan to cap litigation payouts to cancer victims", "image": "https://images.financialmodelingprep.com/news/special-reportinside-jjs-secret-plan-to-cap-litigation-payouts-20220204.jpg", "site": "reuters.com", "text": "Johnson & Johnson created a plan last year to limit the financial bleeding from billions of dollars in jury awards to plaintiffs who alleged the company's Baby Powder and other talc products caused deadly cancers. The healthcare and consumer-goods giant assigned more than 30 staffers to “Project Plato.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/inside-jjs-secret-plan-cap-litigation-payouts-cancer-victims-2022-02-04/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-04T14:23:00-05:00", "date_et": "2022-02-04"}
{"symbol": "JNJ", "publishedDate": "2022-02-04 18:56:00", "publisher": "Reuters", "title": "J&J tried to get federal judge to block publication of Reuters story", "image": "https://images.financialmodelingprep.com/news/jj-tried-to-get-federal-judge-to-block-publication-20220204.jpg", "site": "reuters.com", "text": "Johnson & Johnson tried to get a U.S. judge to block Reuters from publishing a story based on what it said were confidential company documents about the healthcare giant's legal maneuvers to fight lawsuits claiming its Baby Powder caused cancer.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-tried-get-federal-judge-block-publication-reuters-story-2022-02-04/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-04T18:56:00-05:00", "date_et": "2022-02-04"}
{"symbol": "JNJ", "publishedDate": "2022-02-06 08:50:42", "publisher": "The Guardian", "title": "Johnson & Johnson faces push to force global ban on talc baby powder sales", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-faces-push-to-force-global-ban-on-20220206.jpg", "site": "theguardian.com", "text": "Move to hold shareholder vote follows withdrawal of product in US and Canada and lawsuits alleging link to cancer cases", "url": "https://www.theguardian.com/business/2022/feb/06/johnson-johnson-faces-push-to-force-global-ban-on-talc-baby-powder-sales", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-06T08:50:42-05:00", "date_et": "2022-02-06"}
{"symbol": "JNJ", "publishedDate": "2022-02-07 16:51:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-the-cowen-42nd-annual-20220207.jpg", "site": "prnewswire.com", "text": "NEW BRUNSWICK, N.J., Feb. 7, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 42nd Annual Health Care Virtual Conference on Monday, March 7 th.", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-cowen-42nd-annual-health-care-virtual-conference-301476930.html", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-07T16:51:00-05:00", "date_et": "2022-02-07"}
{"symbol": "JNJ", "publishedDate": "2022-02-07 22:24:23", "publisher": "Seeking Alpha", "title": "PFM: Dividend Growth Is Not Enough", "image": "https://images.financialmodelingprep.com/news/pfm-dividend-growth-is-not-enough-20220207.jpg", "site": "seekingalpha.com", "text": "PFM: Dividend Growth Is Not Enough", "url": "https://seekingalpha.com/article/4485001-invesco-pfm-etf-dividend-growth-not-enough", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-07T22:24:23-05:00", "date_et": "2022-02-07"}
{"symbol": "JNJ", "publishedDate": "2022-02-08 11:12:00", "publisher": "Reuters", "title": "J&J pauses production of its COVID-19 vaccine - NYT", "image": "https://images.financialmodelingprep.com/news/jj-pauses-production-of-its-covid19-vaccine-nyt-20220208.jpg", "site": "reuters.com", "text": "(Reuters) -Johnson & Johnson late last year quietly shut down the only plant making usable batches of its COVID-19 vaccine, the New York Times reported, citing people familiar with the decision.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-pauses-production-its-covid-19-vaccine-nyt-2022-02-08/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-08T11:12:00-05:00", "date_et": "2022-02-08"}
{"symbol": "JNJ", "publishedDate": "2022-02-08 11:15:00", "publisher": "The Motley Fool", "title": "3 Top Healthcare Stocks to Buy for February", "image": "https://images.financialmodelingprep.com/news/3-top-healthcare-stocks-to-buy-for-february-20220208.jpg", "site": "fool.com", "text": "Whether you're looking for growth or big dividends, the healthcare sector's got deals galore.", "url": "https://www.fool.com/investing/2022/02/08/3-top-healthcare-stocks-to-buy-for-february/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-08T11:15:00-05:00", "date_et": "2022-02-08"}
{"symbol": "JNJ", "publishedDate": "2022-02-08 11:18:50", "publisher": "Business Insider", "title": "Johnson & Johnson quietly halted production of its COVID-19 vaccines: NYT", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-quietly-halted-production-of-its-covid19-vaccines-20220208.jpg", "site": "businessinsider.com", "text": "The Times reported that the company shut down the only plant making usable vaccine batches in the Netherlands late last year.", "url": "https://www.businessinsider.com/johnson-and-johnson-to-shut-down-coronavirus-vaccine-production-report-2022-2", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-08T11:18:50-05:00", "date_et": "2022-02-08"}
{"symbol": "JNJ", "publishedDate": "2022-02-08 12:34:05", "publisher": "Benzinga", "title": "Johnson & Johnson Halts Production Of Its COVID-19 Vaccine: NYT", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-halts-production-of-its-covid19-vaccine-nyt-20220208.jpeg", "site": "benzinga.com", "text": "Johnson & Johnson  JNJ quietly shut down the only plant making usable batches of its COVID-19 vaccine, the New York Times reported, citing people familiar with the decision. Get the Inside Access Traders Are Using to Profit More and Win Bigger.", "url": "https://www.benzinga.com/general/biotech/22/02/25485923/johnson-johnson-halts-production-of-its-covid-19-vaccine-nyt", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-08T12:34:05-05:00", "date_et": "2022-02-08"}
{"symbol": "JNJ", "publishedDate": "2022-02-08 13:23:05", "publisher": "Forbes", "title": "Johnson & Johnson Reportedly Pauses Covid Vaccine Production Despite Sharp Need In Developing Countries", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reportedly-pauses-covid-vaccine-production-despite-sharp-20220208.jpg", "site": "forbes.com", "text": "Production at a key Covid-19 vaccine plant has been paused though many African nations continue to report low vaccine supplies.", "url": "https://www.forbes.com/sites/zacharysmith/2022/02/08/johnson--johnson-reportedly-pauses-covid-vaccine-production-despite-sharp-need-in-developing-countries/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-08T13:23:05-05:00", "date_et": "2022-02-08"}
{"symbol": "JNJ", "publishedDate": "2022-02-08 13:53:52", "publisher": "CNBC", "title": "Johnson & Johnson plant pauses Covid vaccine production, report says", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-plant-pauses-covid-vaccine-production-report-says-20220208.jpeg", "site": "cnbc.com", "text": "The only Johnson & Johnson facility making usable batches of the company's Covid vaccine has temporarily halted its production, The New York Times reported.", "url": "https://www.cnbc.com/2022/02/08/johnson-johnson-plant-pauses-covid-vaccine-production-report-says.html", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-08T13:53:52-05:00", "date_et": "2022-02-08"}
{"symbol": "JNJ", "publishedDate": "2022-02-08 18:29:34", "publisher": "CNET", "title": "Johnson & Johnson reportedly pauses COVID vaccine production, raising vaccine access concerns", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reportedly-pauses-covid-vaccine-production-raising-vaccine-20220208.jpg", "site": "cnet.com", "text": "The company's one-dose COVID-19 vaccine has been the only option in some parts of the world.", "url": "https://www.cnet.com/health/medical/johnson-johnson-reportedly-pauses-covid-vaccine-production-raising-vaccine-access-concerns/", "ticker": "JNJ", "event_date": "2022-01-25", "window_start": "2022-01-18", "window_end": "2022-02-08", "publishedDateET": "2022-02-08T18:29:34-05:00", "date_et": "2022-02-08"}
